Tuesday, September 1, 2015
Ignyta Announces Entrectinib Clinical Case Report Presentation at the 2015 World Conference on Lung Cancer
… the 2015 World Conference on Lung Cancer
Ignyta, Inc. (Nasdaq: RXDX),
a … a patient with non-small cell lung cancer
harboring an NTRK1 gene rearrangement … Association for the Study of Lung
Cancer’s Scientific Program Committee for … Patient with
NTRK1-Rearranged Non-Small Cell Lung Cancer (NSCLC) (ID number
2913)
Date …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment